{"count":221415,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1788","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1786","results":[{"created":"2020-05-25T17:18:35.289314+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.92","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: DNAH8 were set to ","entity_name":"DNAH8","entity_type":"gene"},{"created":"2020-05-25T17:17:25.298831+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.91","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: DNAH8 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"DNAH8","entity_type":"gene"},{"created":"2020-05-25T17:14:22.431839+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FOXJ1 as ready","entity_name":"FOXJ1","entity_type":"gene"},{"created":"2020-05-25T17:14:22.422249+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: foxj1 has been classified as Green List (High Evidence).","entity_name":"FOXJ1","entity_type":"gene"},{"created":"2020-05-25T17:14:18.677515+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FOXJ1 as Green List (high evidence)","entity_name":"FOXJ1","entity_type":"gene"},{"created":"2020-05-25T17:14:18.666268+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: foxj1 has been classified as Green List (High Evidence).","entity_name":"FOXJ1","entity_type":"gene"},{"created":"2020-05-25T17:11:34.383387+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NFKB1 as ready","entity_name":"NFKB1","entity_type":"gene"},{"created":"2020-05-25T17:11:34.377651+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Not a PCD, but overlapping clinical features.","entity_name":"NFKB1","entity_type":"gene"},{"created":"2020-05-25T17:11:34.335615+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nfkb1 has been classified as Amber List (Moderate Evidence).","entity_name":"NFKB1","entity_type":"gene"},{"created":"2020-05-25T17:11:31.458910+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NFKB1 as Amber List (moderate evidence)","entity_name":"NFKB1","entity_type":"gene"},{"created":"2020-05-25T17:11:31.446402+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.90","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nfkb1 has been classified as Amber List (Moderate Evidence).","entity_name":"NFKB1","entity_type":"gene"},{"created":"2020-05-25T17:10:37.058616+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NFKB2 as ready","entity_name":"NFKB2","entity_type":"gene"},{"created":"2020-05-25T17:10:37.054393+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Not a PCD, but can have overlapping presenting features.","entity_name":"NFKB2","entity_type":"gene"},{"created":"2020-05-25T17:10:37.022641+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nfkb2 has been classified as Amber List (Moderate Evidence).","entity_name":"NFKB2","entity_type":"gene"},{"created":"2020-05-25T17:10:19.102970+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NFKB2 as Amber List (moderate evidence)","entity_name":"NFKB2","entity_type":"gene"},{"created":"2020-05-25T17:10:19.093848+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.89","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nfkb2 has been classified as Amber List (Moderate Evidence).","entity_name":"NFKB2","entity_type":"gene"},{"created":"2020-05-25T17:09:17.094220+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2898","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NME8 as ready","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:09:17.081898+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2898","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:09:08.797046+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2898","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NME8 were changed from  to Ciliary dyskinesia, primary, 6, MIM# 610852","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:08:35.803307+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2897","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NME8 were set to ","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:07:57.207286+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2896","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NME8 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:07:37.361106+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2895","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NME8 as Red List (low evidence)","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:07:37.347583+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2895","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:07:00.726231+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NME8 as ready","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:07:00.716102+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:06:58.036042+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NME8 were changed from  to Ciliary dyskinesia, primary, 6, MIM# 610852","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:06:26.839051+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.45","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NME8 were set to ","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:05:56.698129+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NME8 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:05:29.272832+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NME8 as Red List (low evidence)","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:05:29.263908+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:04:28.627095+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NME8 as ready","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:04:28.614812+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:04:24.923863+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.88","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NME8 were changed from  to Ciliary dyskinesia, primary, 6, MIM# 610852","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:03:51.696085+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.87","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NME8 were set to ","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:03:22.102207+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.86","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NME8 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:02:54.221091+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.85","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NME8 as Red List (low evidence)","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:02:54.209778+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.85","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nme8 has been classified as Red List (Low Evidence).","entity_name":"NME8","entity_type":"gene"},{"created":"2020-05-25T17:02:39.979496+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.66","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: TMEM231 as ready","entity_name":"TMEM231","entity_type":"gene"},{"created":"2020-05-25T17:02:39.957872+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.66","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: tmem231 has been classified as Green List (High Evidence).","entity_name":"TMEM231","entity_type":"gene"},{"created":"2020-05-25T17:02:36.971422+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.66","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: TMEM231 as Green List (high evidence)","entity_name":"TMEM231","entity_type":"gene"},{"created":"2020-05-25T17:02:36.958160+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.66","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: tmem231 has been classified as Green List (High Evidence).","entity_name":"TMEM231","entity_type":"gene"},{"created":"2020-05-25T17:02:23.979244+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.65","user_name":"Bryony Thompson","item_type":"entity","text":"gene: TMEM231 was added\ngene: TMEM231 was added to Syndromic Retinopathy. Sources: Expert list\nMode of inheritance for gene: TMEM231 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: TMEM231 were set to 23012439; 27449316\nPhenotypes for gene: TMEM231 were set to Joubert syndrome 20 MIM#614970\nReview for gene: TMEM231 was set to GREEN\nAdded comment: Three unrelated families reported with retinopathy as a feature of the condition. \nSources: Expert list","entity_name":"TMEM231","entity_type":"gene"},{"created":"2020-05-25T17:01:45.212373+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2894","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TFAP2A as ready","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T17:01:45.198456+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2894","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tfap2a has been classified as Green List (High Evidence).","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T17:01:28.321462+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2894","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TFAP2A were changed from  to Branchiooculofacial syndrome, MIM 113620","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T17:01:08.855601+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2893","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TFAP2A were set to ","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T17:00:48.477501+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2892","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of pathogenicity for gene: TFAP2A was changed from  to Other","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T17:00:30.427582+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2891","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TFAP2A was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TFAP2A","entity_type":"gene"},{"created":"2020-05-25T16:59:41.439102+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PIK3CD as ready","entity_name":"PIK3CD","entity_type":"gene"},{"created":"2020-05-25T16:59:41.435057+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Include as overlapping phenotype.","entity_name":"PIK3CD","entity_type":"gene"},{"created":"2020-05-25T16:59:41.403352+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pik3cd has been classified as Amber List (Moderate Evidence).","entity_name":"PIK3CD","entity_type":"gene"},{"created":"2020-05-25T16:59:38.429698+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PIK3CD as Amber List (moderate evidence)","entity_name":"PIK3CD","entity_type":"gene"},{"created":"2020-05-25T16:59:38.417998+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.84","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pik3cd has been classified as Amber List (Moderate Evidence).","entity_name":"PIK3CD","entity_type":"gene"},{"created":"2020-05-25T16:58:29.255734+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PIK3R1 as ready","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:58:29.249759+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Can cause bronchiectasis with limited immunological findings, include as an overlapping phenotype on this panel.","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:58:29.206523+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pik3r1 has been classified as Amber List (Moderate Evidence).","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:58:09.253578+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PIK3R1 as Amber List (moderate evidence)","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:58:09.241088+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.83","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pik3r1 has been classified as Amber List (Moderate Evidence).","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:57:11.209963+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PIK3R1 as Red List (low evidence)","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:57:11.200899+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pik3r1 has been classified as Red List (Low Evidence).","entity_name":"PIK3R1","entity_type":"gene"},{"created":"2020-05-25T16:54:55.290592+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: VIPAS39 as ready","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:54:55.278464+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: vipas39 has been classified as Green List (High Evidence).","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:54:52.403370+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: VIPAS39 were changed from  to Arthrogryposis, renal dysfunction, and cholestasis 2, MIM#613404","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:54:23.131183+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: VIPAS39 were set to ","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:53:55.602056+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: VIPAS39 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:52:46.248405+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAH6 as ready","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:52:46.229991+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah6 has been classified as Amber List (Moderate Evidence).","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:52:42.458210+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH6 as Amber List (moderate evidence)","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:52:42.449374+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah6 has been classified as Amber List (Moderate Evidence).","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:51:51.082037+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAH6 as ready","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:51:51.067966+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah6 has been classified as Amber List (Moderate Evidence).","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:51:40.889941+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: DNAH6 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:51:01.370056+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH6 as Amber List (moderate evidence)","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:51:01.360892+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah6 has been classified as Amber List (Moderate Evidence).","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:50:32.963551+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DNAH6: Rating: AMBER; Mode of pathogenicity: None; Publications: 26918822; Phenotypes: Heterotaxy, male infertility; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"DNAH6","entity_type":"gene"},{"created":"2020-05-25T16:47:33.273045+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.64","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: TMEM107 as ready","entity_name":"TMEM107","entity_type":"gene"},{"created":"2020-05-25T16:47:33.260269+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.64","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: tmem107 has been classified as Amber List (Moderate Evidence).","entity_name":"TMEM107","entity_type":"gene"},{"created":"2020-05-25T16:47:28.736100+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.64","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: TMEM107 as Amber List (moderate evidence)","entity_name":"TMEM107","entity_type":"gene"},{"created":"2020-05-25T16:47:28.726849+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.64","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: tmem107 has been classified as Amber List (Moderate Evidence).","entity_name":"TMEM107","entity_type":"gene"},{"created":"2020-05-25T16:47:12.170914+10:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.63","user_name":"Bryony Thompson","item_type":"entity","text":"gene: TMEM107 was added\ngene: TMEM107 was added to Syndromic Retinopathy. Sources: Expert list\nMode of inheritance for gene: TMEM107 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: TMEM107 were set to 26595381\nPhenotypes for gene: TMEM107 were set to Joubert syndrome 29 MIM#617562; Orofaciodigital syndrome XVI MIM#617563\nReview for gene: TMEM107 was set to AMBER\nAdded comment: A set of twins and an unrelated case reported with retinopathy as a feature of the condition. \nSources: Expert list","entity_name":"TMEM107","entity_type":"gene"},{"created":"2020-05-25T16:47:11.905440+10:00","panel_name":"Pierre Robin Sequence","panel_id":160,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BMPR1B as Amber List (moderate evidence)","entity_name":"BMPR1B","entity_type":"gene"},{"created":"2020-05-25T16:47:11.892852+10:00","panel_name":"Pierre Robin Sequence","panel_id":160,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bmpr1b has been classified as Amber List (Moderate Evidence).","entity_name":"BMPR1B","entity_type":"gene"},{"created":"2020-05-25T16:46:00.996536+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFTR as ready","entity_name":"CFTR","entity_type":"gene"},{"created":"2020-05-25T16:46:00.986549+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cftr has been classified as Green List (High Evidence).","entity_name":"CFTR","entity_type":"gene"},{"created":"2020-05-25T16:45:55.719784+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFTR were changed from Disseminated bronchiectasis to Cystic fibrosis; bronchiectasis","entity_name":"CFTR","entity_type":"gene"},{"created":"2020-05-25T16:45:18.413762+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFTR as Green List (high evidence)","entity_name":"CFTR","entity_type":"gene"},{"created":"2020-05-25T16:45:18.404972+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cftr has been classified as Green List (High Evidence).","entity_name":"CFTR","entity_type":"gene"},{"created":"2020-05-25T16:44:28.178848+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.21","user_name":"Chern Lim","item_type":"entity","text":"changed review comment from: PMID:20190753: 7 unrelated ARC patients hom/chet with protein-truncating variants. Knockdown of gene in zebrafish resulted in biliary excretion and E-cadherin defects similar to those in individuals with ARC.; to: PMID:20190753: 7 unrelated ARC patients hom/chet with protein-truncating variants or start-loss variant. Knockdown of gene in zebrafish resulted in biliary excretion and E-cadherin defects similar to those in individuals with ARC.","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:39:57.278218+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFAP54 as ready","entity_name":"CFAP54","entity_type":"gene"},{"created":"2020-05-25T16:39:57.268964+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfap54 has been classified as Red List (Low Evidence).","entity_name":"CFAP54","entity_type":"gene"},{"created":"2020-05-25T16:39:02.794182+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFAP54 as Red List (low evidence)","entity_name":"CFAP54","entity_type":"gene"},{"created":"2020-05-25T16:39:02.785474+10:00","panel_name":"Ciliary Dyskinesia","panel_id":82,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfap54 has been classified as Red List (Low Evidence).","entity_name":"CFAP54","entity_type":"gene"},{"created":"2020-05-25T16:37:00.848719+10:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.21","user_name":"Chern Lim","item_type":"entity","text":"reviewed gene: VIPAS39: Rating: GREEN; Mode of pathogenicity: None; Publications: 20190753; Phenotypes: Arthrogryposis, renal dysfunction, and cholestasis 2, MIM#613404; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal; Current diagnostic: yes","entity_name":"VIPAS39","entity_type":"gene"},{"created":"2020-05-25T16:35:12.772482+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFAP53 as ready","entity_name":"CFAP53","entity_type":"gene"},{"created":"2020-05-25T16:35:12.759970+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfap53 has been classified as Green List (High Evidence).","entity_name":"CFAP53","entity_type":"gene"},{"created":"2020-05-25T16:35:07.599365+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFAP53 as Green List (high evidence)","entity_name":"CFAP53","entity_type":"gene"},{"created":"2020-05-25T16:35:07.589600+10:00","panel_name":"Heterotaxy","panel_id":108,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfap53 has been classified as Green List (High Evidence).","entity_name":"CFAP53","entity_type":"gene"},{"created":"2020-05-25T16:26:26.302583+10:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADGRG1 as ready","entity_name":"ADGRG1","entity_type":"gene"},{"created":"2020-05-25T16:26:26.294145+10:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adgrg1 has been classified as Green List (High Evidence).","entity_name":"ADGRG1","entity_type":"gene"},{"created":"2020-05-25T16:26:23.152395+10:00","panel_name":"Polymicrogyria and Schizencephaly","panel_id":18,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADGRG1 were changed from  to Polymicrogyria, bilateral frontoparietal, MIM#606854","entity_name":"ADGRG1","entity_type":"gene"}]}